Japan, Stalled On Frontier Science Plan

Japan's effort to launch an international program in basic biological research has stalled again amid continued confusion over its specifics, according to U.S. and Japanese sources familiar with the project. The latest setback to the Human Frontier Science Program came earlier this month at the Venice economic summit, where Prime Minister Yasuhiro Nakasone had been expected to unveil an official proposal. Instead, final details of the program remain under wraps, and the seven leaders of major in

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The latest setback to the Human Frontier Science Program came earlier this month at the Venice economic summit, where Prime Minister Yasuhiro Nakasone had been expected to unveil an official proposal. Instead, final details of the program remain under wraps, and the seven leaders of major industrial nations, in a single paragraph far down in the summit communiqué, issued only a general endorsement of the concept.

"We welcome the initiative of the Human Frontier Science Program," the document said, noting that the feasibility study by Japan "will be continued, and we would be pleased to be kept informed about its progress."

That progress has been fitful since early last year, when Japan's Ministry of International Trade and Industry (MITI) revealed its plan for an international program of basic research into human biological functions. After the Science and Technology Agency weighed in with its own proposal, Nakasone ordered MITI, STA, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Alan Engel

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo